Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Welichem begins new initiatives with Chinese partners

Nov. 17, 2005

Quest PharmaTech to investigate ACP-SL017 for hair removal and acne

Nov. 14, 2005

Epitan reports results from European PMLE phase II study of EPT-1647

Nov. 11, 2005

Phosphate binders show promise in the treatment of pseudoxanthoma elasticum

Nov. 10, 2005

Recent patents disclose novel agents for dermatological disorders

Nov. 9, 2005

ISA-247 reported effective in moderate to severe psoriasis

Nov. 8, 2005

Remicade sBLA for plaque psoriasis accepted for filing

Nov. 8, 2005

Maruho and Toray enter codevelopment agreement for TRK-820 in Europe

Nov. 4, 2005

Amygdalin peptidomimetics present improved profile as potential antipsoriatic agents

Oct. 31, 2005

Enrollment completed in phase I/II eczema study of Avrina

Oct. 31, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...